SGMT

9.0805.61%
TC

Thierry Chauche

CFO & Principal Accounting Officer

Mr. Thierry Chauche serves as Chief Financial Officer & Principal Accounting Officer of Sagimet Biosciences Inc. since May 06, 2024. He was Chief Financial Officer of Provention Bio, Inc. since joining on December 1, 2021 until April 27, 2023. Mr. Chauche has many years of financial and operational leadership experience in finance and healthcare companies. He joined Provention from Alexion Pharmaceuticals where he was the Head of Strategic Financial Planning and Analysis from 2020 to 2021. Prior to Alexion, Mr. Chauche served in roles of increasing responsibility at Intercept Pharmaceuticals from 2017 to 2020, Novartis from 2007 to 2017 and Rothschild & Cie from 1999 to 2005. He served as Chief Financial Officer of Provention Bio, a publicly traded biopharmaceutical company focused on intercepting and preventing immune-mediated diseases including Type 1 Diabetes, where he built up and led finance, investor relations and information technology teams supporting market creation and a transformational therapeutic launch and commercialization. At Provention, he also focused on the successful execution of several financings and an M&A strategy leading to acquisition of the company by Sanofi. Before Provention Bio, Mr. Chauche was the Vice President and Head of Strategic Financial Planning & Analysis at Alexion Pharmaceuticals. Prior to Alexion Pharmaceuticals, he served in roles of increasing responsibility at Intercept Pharmaceuticals, Novartis and Rothschild & Cie. Mr. Chauche holds an MBA from the Wharton School at the University of Pennsylvania and a MS in engineering from Ecole des Ponts ParisTech in Paris, France.

Positions